Iconic Brands (ICNB). Liked it at $0.20, Love it at $0.09.

With Upcoming 9 Month Revenues Expected to be 3X Last Years Revenues, Still one of our Favorites. LIVE QUOTE

Provention Bio (PRVB) Gains 26% Last Week.

We're up 106% From Adding to the 2022 Watch List Last July. And up 26% a Week After Urging Holders to Calm...

FDA Approves Most Expensive Drug Ever, @ $3.5 Million-Per-Dose, from uniQure (QURE).

Important to note, the FDA didn't approve the price, they approved the drug. It was priced afterwards. Second item it is a...

FDA Approval for Provention Bio (PRVB).

Re-cork the Champagne! We were contemplating (dreaming) about an opening price over $12, and then a drift up...

Adding Ardelyx (ARDX) $1.57 to Watch List.

FDA Advisory Committee Says Go Forth Young Man! While we hadn't previously owned Ardelyx, nor are they a...

Provention Biosciences (PRVB) Enters the Danger Zone.

Chart Looks Beautiful - But Nervous is why, we use soft and dry. LIVE QUOTE We'll...

DCS (DCSX) and Cellcom Enhance Partnership for IoT Solutions

LIVE QUOTE San Diego, California--(Newsfile Corp. - November 14, 2022) - Direct Communication Solutions,...

VERU (VERU) $6.66, Goes Poof.

Veru Provides Update on FDA Advisory Committee Meeting Market Cap Plunges from...

Top Beverage Companies for 2023 and Beyond.

Here's Our Favorite Alcohol, Non-Alcohol and Exciting Privately Held Beverage Start-Ups. Chicago IL / Beverage News Wire...

Progressive Care Launches Native Remote Patient Monitoring Mobile App .

Progressive Care Launches Native Remote Patient Monitoring Mobile App and Physician Portal to Remotely Manage Chronic and Transitional Care

Latest article

Nine Page Summary Report on GeoVax (GOVX)

This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier...

GeoVax (GOVX) Provides First Half 2024 Business Update.

Award of BARDA Project NextGen contract represents a significant milestone event; Total value...

Reverse Split Mania! Solgenix (SNGX) Jumps 448% After 1:16.

Can You Imagine Selling Solgenix at $2.00 yesterday. And to be honest, news wasn't all that big - such...